{"organizations": [], "uuid": "439d58009ba68d106ccaf9b0a55cd31483272075", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180518.html", "section_title": "Archive News &amp; Video for Friday, 18 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-editas-medicine-reports-data-demon/brief-editas-medicine-reports-data-demonstrating-subretinal-injection-of-edit-101-well-tolerated-in-non-human-primates-idUSFWN1SP0VG", "country": "US", "domain_rank": 408, "title": "BRIEF-Editas Medicine Reports Data Demonstrating Subretinal Injection Of Edit-101 Well-Tolerated In Non-Human Primates", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-05-19T05:07:00.000+03:00", "replies_count": 0, "uuid": "439d58009ba68d106ccaf9b0a55cd31483272075"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-editas-medicine-reports-data-demon/brief-editas-medicine-reports-data-demonstrating-subretinal-injection-of-edit-101-well-tolerated-in-non-human-primates-idUSFWN1SP0VG", "ord_in_thread": 0, "title": "BRIEF-Editas Medicine Reports Data Demonstrating Subretinal Injection Of Edit-101 Well-Tolerated In Non-Human Primates", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "non-human primates editas medicine inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Editas Medicine Inc:\n* EDITAS MEDICINE REPORTS DATA DEMONSTRATING SUBRETINAL INJECTION OF EDIT-101 WELL-TOLERATED IN NON-HUMAN PRIMATES\n* EDITAS MEDICINE INC - BOTH EDIT-101 AND VIR-067 WERE WELL TOLERATED IN ANIMALS TREATED WITH PROPHYLACTIC STEROIDS\n* EDITAS MEDICINE INC - EDITAS MEDICINE AIMS TO FILE AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR EDIT-101 BY MID-2018 Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-19T05:07:00.000+03:00", "crawled": "2018-05-19T15:17:42.016+03:00", "highlightTitle": ""}